Cell replacement therapy using mesencephalic precursor cells is an experimental approach for the treatment of Parkinson's disease (PD). A significant problem associated with this procedure is the poor survival of grafted neurons. Impaired energy metabolism is considered to contribute to neuronal cell death after transplantation. Creatine is a substrate for mitochondrial and cytosolic creatine kinases (CK) and buffers cellular ATP resources. Furthermore, elevated cellular creatine levels facilitate metabolic channeling and show antiapoptotic properties. Exogenous creatine supplementation therefore might offer a tool for improvement of dopaminergic neuron survival. The present study aimed at investigating the effects of creatine on cell survival of rat embryonic day 14 (E14) ventral mesencephalic neurons grown as organotypic free-floating roller tube (FFRT) cultures. We found that the brain-specific isoform of CK (BB-CK) and the ubiquitous mitochondrial isoform (uMt-CK) are expressed at high levels in FFRT cultures and colocalize with tyrosine hydroxylase immunoreactive (TH-ir) cells. Exposure of these cultures to creatine induced an increase in the content of the BB-CK isotype. Creatine (5 mM) administration starting at day in vitro (DIV) 7 resulted in a significant increase (+35%) in TH-ir cell density at DIV21. In addition, we observed that creatine treatment provided neuroprotection against 1-methyl-4-phenyl pyridinium ion (MPP + )-induced TH-ir cell loss in the FFRT culture system, resulting in a significantly higher density (+19%) of TH-ir neurons in creatine-treated cultures compared to corresponding controls. The decrease of TH-ir neurons in the MPP + -treated group corresponded with an increase in immunoreactivity for active caspase-3, an effect that was not seen in the group receiving creatine supplementation. In conclusion, our data imply that creatine administration is beneficial for the survival of TH-ir neurons encountering harmful conditions. 537 538 ANDRES ET AL.
INTRODUCTION
mal metabolic conditions are required during the in vitro storage period to prevent cell loss due to metabolic and oxidative stress (88) . Furthermore, release of toxic me-Transplantation of embryonal ventral mesencephalic cells is an experimental therapy for the treatment of tabolites and neurotransmitters with excitotoxic potential, such as dopamine (10) and glutamate (33) , from medically intractable Parkinson's disease (PD) and has been shown to be effective in reinnervating the host stri-dying cells contributes to an unfavorable environment and potentiate cell death (79) . So far, culture conditions atum (31, 32, 54, 69) . However, limited availability of human embryonal tissue originating from legal abortions, are still suboptimal compared to the in vivo environment, resulting in an unsatisfactory survival of dopamin-ethical concerns, and the poor survival of the grafts impair a widespread clinical application. Collecting and ergic neurons. The phosphocreatine/creatine kinase system has been pooling tissue from multiple donors, in vitro conditioning (18, 59, 89, 91) , and exposure to neurotrophins (48, 91) , described to play an important role in cellular energy homeostasis in cells with high and fluctuating energy antiapoptotic factors (42, 65, 80) , or antioxidative agents (35, 71) are promising strategies to reduce the amount of demands, like neurons, by acting as a temporal and spatial ATP buffer (93, 94) . Creatine (1-methyl-guanidi-tissue required to achieve a sufficient number of surviving functional dopaminergic neurons in the grafts. Opti-noacetic acid) supplementation has been shown to in-crease the intracellular phosphocreatine level and buffers were carefully excised from the cranium (26), transferred to a petri dish with Dulbecco's modified Eagle cellular ATP resources under metabolic and/or oxidative stress (61, 95, 96, 97) , to act as a substrate for a cellular medium (DMEM; Gibco), and the ventral mesencephali (VM) dissected according to standard procedures (89). energy shuttle (20, 43, 44) and to inhibit apoptosis by means of stabilizing the mitochondrial permeability transi-
The mesencephalic explants (2 × 1.5 × 1 mm in size) were cut into four equally large quadrants by a sagittal tion (14, 44, 68, 73) . Moreover, there is evidence that defects in creatine utilization are directly involved in the and a coronal incision and transferred into gas-permeable conical plastic tubes (Falcon), supplied with 1 ml pathogenesis of several neurological diseases (3, 4, 11, 82, 98) . In line with these notions, recent studies demon-of culture medium consisting of 55% DMEM, 32.5% Hank's balanced salt solution (HBSS; Gibco), 0.3% glu-strated a neuroprotective effect of creatine supplementation in a variety of experimental models of neurological cose, 10% fetal calf serum (FCS; Gibco), and 1% 0.01 M HEPES (Merck). The tubes were placed in a slowly disorders including PD, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and ischemia (2,6,
(1 rev/min) rotating roller-drum (36) placed in an incubator at 37°C in a 5% CO 2 atmosphere as described in 7, 23, 57, 58) .
Knowledge on the functional effects of the creatine detail previously (89). The culture tubes were randomly assigned to either the creatine-treated or to the control kinase/phosphocreatine system regarding the metabolism of embryonic neurons is limited. In rat embryonal group. Maintenance medium was changed every fourth day with antibiotics/antimycotics (No. 061-05240 D; brain tissue, the creatine kinase isoenzymes BB-CK (brain-specific cytosolic isotype) and uMt-CK (ubiqui-Gibco) present during the first 4 days in culture. All animal procedures were approved by the Animal Care tous mitochondrial isotype) have been described to be present in moderate quantities at embryonic day 14 and Use Committee at the University of Berne. (E14), to decrease slightly during the further period in Creatine Treatment and Tissue Processing utero, and to increase rapidly up to adult levels in the early postnatal period (46) . Enzyme activity assays have FFRT cultures were kept in standard culture medium. In the treatment groups, creatine monohydrate (Creapur-shown similar results for total CK activity in the developing rat brain (20, 46) , indicating an important role of e TM ; SKW Trostberg) was added to the culture medium at a final concentration of 5 mM from day in vitro 7 CK and presumably also its substrate, creatine, for brain development and viability of brain cells. Indeed, in adult (DIV7) to DIV21 at each medium change, while no creatine was added to the control groups. The concentration hippocampal neurons, creatine showed protection against glutamate excitotoxicity and β-amyloid precursor pro-of 5 mM was chosen due to the maximal effects found on survival of dopaminergic neurons in mesencephalic tein (15) . Creatine supplementation may therefore also be effective in improving the metabolic state of embry-cultures in a pilot study (Andres et al., unpublished data) . Furthermore, Brustovetsky and coworkers re-onic neurons and neuronal precursors and thus constitute a means of improving cell viability and long-term sur-ported creatine concentrations of 3 and 10 mM to exert neuroprotection against an energetic insult in hippocam-vival of cells for subsequent transplantation.
Organotypic tissue cultures like the free-floating pal and striatal cultures, while lower doses turned out to be ineffective (19) . Analyses proved that the concentra-roller tubes (FFRT) culture system (89) offer advantages for transplantation by preserving the complex functional tion of the added creatine in the culture medium remained stable over the interval between the medium and structural interaction of the nigral neurons at least partially. In the present study, we investigated whether changes (48 h). Levels of endogenous creatine derived from the FCS content in the maintenance culture me-creatine supplementation has beneficial effects on the survival of embryonal mesencephalic dopaminergic neu-dium were determined to be much lower (45 µmol/L) as determined to be effective in influencing survival of rons in FFRT cultures and addressed the possible protective properties against 1-methyl-4-phenylpyridinium ion neurons (i.e., >1 mM; Andres and Widmer, unpublished data). Creatine contents in the culture medium were as-(MPP + )-induced cell death, which provides an effective model of PD in vitro. sessed using standardized clinical enzymatic assays (Chemical Central Laboratories, University Hospital, Berne).
MATERIALS AND METHODS
Cultures for immunohistochemistry were washed Preparation of Organotypic Cultures twice with ice cold HBSS before fixation in 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS; After induction of deep pentobarbital anesthesia (Nembutal TM , 100 mg/kg body weight; Abbott), E14 fe-pH 7.4) for 45 min at room temperature. Control cultures were fixed at DIV7 (n = 12, two independent ex-tuses were removed by cesarean section from pregnant Sprague-Dawley rats (RCC Biotechnology, Füllinsdorf, periments), DIV14 (n = 24, two independent experiments), and DIV21 (n = 48, three independent experiments), while Switzerland) and killed by decapitation. The fetal brains creatine-treated cultures were stopped and fixed at DIV14 2.5% HS at 4°C. Following four washes, sections were incubated with a biotinylated secondary antibody (horse (n = 12, two independent experiments) and DIV21 (n = 48, three independent experiments). The four cultures anti-rabbit 1:200; Vector Labs) in 0.05% Triton X-100 in PBS plus 2.5% HS for 90 min. Endogenous peroxi-corresponding to one VM were pooled. Tissue was then rinsed three times in 0.1 M PBS, equilibrated in 15% dase was blocked by 3% H 2 O 2 and 10% methanol in PBS for 10 min. Following incubation with an avidin-sucrose in 0.1 M phosphate buffer solution containing 0.01% NaN 3 , and cut at 20 µm on a freezing microtome peroxidase complex (1:150; Vector Labs) for 45 min, specifically bound antibody was visualized with a metal-(Frigocut 2800 N; Reichert-Jung). Slices were mounted on gelatine chrome-alum precoated glass slides.
enhanced DAB substrate kit (No. 34065; Pierce) for 3-5 min. Sections were dehydrated in alcohol, cleared in xy-To assess the protective potential of creatine against dopaminergic cell loss induced by MPP + (Sigma), cul-lene, and mounted in Eukitt. tures (n = 72, two independent experiments) were grown TH Colocalization of TH With BB-CK or uMt-CK in vitro for 7 days. MPP + was added to the culture medium at a final concentration of 15 µM at DIV3 and To perform colocalization studies, tissue sections were preincubated after three rinses in PBS in a buffer DIV5 without (n = 24) or with concurrent creatine supplementation (5 mM) (n = 24), added 2 h prior to MPP + solution containing 0.5 M NaCl, 50 mM Tris-HCl, 5% bovine serum albumin (BSA; Sigma), and 2% milk pow- (74) . Cultures receiving no MPP + in the absence of creatine served as controls (n = 24). For analysis of active der in aqua destillatum (20) for 60 min, washed, and incubated overnight with the primary antibodies [rabbit caspase-3-immunoreactive cells in the cultures, experiments were performed with an identical setup (n = 24, anti-BB-CK or rabbit anti-uMt-CK, respectively, 1:1000 (81), and mouse anti-TH, 1:500; Boehringer Mannheim] two independent experiments). Cultures were stopped and fixed at DIV7 as described above.
in the buffer solution at 4°C. Following three washes, sections were incubated with the secondary antibodies For time course analysis of BB-CK expression cultures were grown for 7, 14, or 21 days in vitro (n = 4, (FITC-labeled anti-mouse 1:50 and TRITC-labeled antirabbit 1:100; DAKO, Denmark) in the buffer solution for each group, two independent experiments) and processed for immunoblot analysis as described below.
for 2 h. Slides were coverslipped in PBS containing 25% glycerol and immunofluorescence was performed at ex-Tyrosine Hydroxylase Immunohistochemistry citation wavelengths of 490 and 557 nm on an epifluorescence microscope (DMRB; Leica). Specifity of BB-CK Every sixth section was selected for tyrosine hydroxylase (TH) immunohistochemistry. After three rinses in and uMt-CK immunostaining was determined by incubation with preimmune serum. PBS, tissue sections were preincubated in 0.3% Triton X-100 in PBS plus 10% horse serum (HS) for 60 min, Western Blot Analysis washed, and incubated overnight with the primary antibody (mouse monoclonal anti-TH, 1:500; Boehringer Immunoblot analyses were carried out according to the method of Laemmli (53) with some modifications. Mannheim) in 0.1% Triton X-100 in PBS plus 2.5% HS at 4°C. Following three washes, sections were incubated Four cultures of the same group were pooled; the culture medium was dipped off and the tissue was rinsed twice with a biotinylated secondary antibody (horse antimouse 1:200; Vector Labs) in 0.1% Triton X-100 in with 7 ml sterile ice-cold HBSS and transferred into an Eppendorf tube with 150 µl of lysis buffer containing PBS plus 2.5% HS for 90 min. Endogenous peroxidase was blocked by 3% H 2 O 2 and 10% methanol in PBS for leupeptin (1 µl/ml), phenylmethylsulfonyl fluoride (PMSF, 5 µl/ml), β-mercaptoethanol (1 mM), EDTA (0.2 mM), 10 min. Following incubation with an avidin-peroxidase complex (1:150; Vector Labs) for 45 The brain-specific cytosolic isoenzyme of creatine ki-4% fat-free milk powder in TBS and incubated with the nase (BB-CK) was present in detectable amounts at all primary antibodies [mouse monoclonal anti-BB-CK, 1: time points assessed. Compared with untreated controls, 1000 (87); mouse monoclonal anti-tyrosine hydroxylase, chronic creatine treatment induced significantly higher 1:500, Pharmingen; rabbit polyclonal anti-neuron-specific levels of BB-CK in the cultures at DIV7 (+45%), while enolase, 1:500, Chemicon; mouse monoclonal anti-β-IIIhaving no significant effects at later time points ( . Analysis of TH expression in untreated control culbulin, 1:20000, Sigma] for 60 min at 22°C in the same tures revealed a significant increase from DIV7 to solution. The blots were washed twice in TBS and sub-DIV14 and from DIV14 to DIV21. Chronic creatine exsequently incubated with antibody-peroxidase conposure did not result in altered TH levels (Fig. 1B) . jugates (goat anti-mouse or goat anti-rabbit, 1:20000;
Colocalization of TH With Creatine Kinases Boehringer Mannheim) for 45 min at 22°C in PBS containing 4% milk powder. Blots were washed three times All TH-ir neurons showed distinct colocalization in TBS and incubated for 1 min in chemiluminescent with BB-CK and uMt-CK (Fig. 2) . Beside cells with substrate (Western Lightning, Perkin-Elmer Life Scineuronal morphology, glial cells were also found to be ence, Hünenberg, Switzerland). Amplified chemilumiimmunoreactive for both creatine kinase isoenzymes nescence was detected and quantified using a digital (data not shown). No effects of creatine treatment on imaging system (ImageStation; Kodak, USA). Band inthe distribution of CK expression between neuronal and tensities were normalized to α-tubulin.
nonneuronal cells was seen. Low signals were obtained for both BB-CK and uMt-CK as well as for TH in the Analysis of Histological Sections and Statistics central area of the cultures. This finding is consistent Cell counts and measurements of culture volumes with the fact that centrally located cells in FFRT cultures were carried out in a blinded experimental design under are subject to necrosis. bright field illumination using a microscope (Axioplan;
Effects of Creatine on Culture Volumes, TH-ir Cell Zeiss) connected to a digital image processing system Numbers, and TH-ir Cell Density (Lucia 4.50; Nikon). Only cells with a distinct immunoreactivity, clear neuronal shape, and a nucleus were
In cultures kept in vitro up to DIV14, the mean density of TH-ir neurons was 64.4 ± 2.9 cells per mm 2 in counted as TH-positive or active caspase-3-positive neurons, respectively. Cell numbers were corrected for dou-the group receiving standard maintenance medium and 62.4 ± 5.3 cells per mm 2 in the group supplemented with ble counting according to Abercrombie's formula (1), using the mean diameter of the nuclei. Estimations of creatine. Culture volumes (0.46 ± 0.03 vs. 0.53 ± 0.01 mm 3 ) and number of TH-ir cells per culture (1361 ± 83 cell numbers were carried out as described previously (45, 60) . In brief, the density of cultured TH-ir neurons vs. 1187 ± 51 cells) did not differ between the treated and the untreated group. Therefore, no significant effects was assessed by counting the numbers on every sixth culture section throughout the explant. The number of of the creatine treatment could be observed at this time point. active caspase-3-ir neurons was estimated by counting three 20-µm sections within a 240-µm range, represent-In a second series of experiments, effects of creatine treatment were assessed over a prolonged time period of ing the central portion of the culture. Culture volumes were assessed by computer-assisted image analysis. As 21 days in vitro. An untreated control group was stopped at DIV14 to ensure comparability with the previous ex-FFRT cultures, the VM tissue pieces assume a spherical shape within a few days and therefore culture volumes periments. In untreated controls stopped at different time points, the culture volumes significantly decreased from can be approximated by measuring the area of the most central section through the culture and calculating the 0.95 ± 0.03 at DIV7 to 0.53 ± 0.01 at DIV14 and subsequently to 0.26 ± 0.02 mm 3 at DIV21 (Fig. 3A) , with a volume of the corresponding sphere (89).
For statistical analysis, a commercially available soft-corresponding decrease in the number of TH-ir neurons (2722 ± 491, 1361 ± 83, and 458 ± 53, respectively; Fig. ware package was used (Statistica 5.0; StatSoft). Cell counts and measurements were expressed as the mean ± 3B) and in the density of TH-ir cells (73.1 ± 5.2, 64.4 ± 2.9, and 44.8 ± 4.1 cells per mm 2 , respectively; Fig. 3C ). SEM. The experimental groups were compared by multivariate analysis of variance (MANOVA), followed by Chronic creatine exposure starting at DIV7 resulted in a significant increase in the number of TH-ir cells per cul-A significant decrease in the tissue content of TH protein after MPP + exposure and partial protection by ture, as assessed at DIV21 and compared against untreated controls (620 ± 67 vs. 458 ± 53 cells, 35% in-concurrent creatine treatment was also confirmed by Western blotting analysis of FFRT cultures at DIV7 crease; Fig. 3E ). The VM culture volume at DIV21 was not significantly affected by the creatine treatment, com-( Fig. 7) . No effect of MPP + and creatine was found on expression levels of the neuronal markers neuron-specific pared against controls (0.28 ± 0.02 vs. 0.26 ± 0.02 mm 3 , 7.7% increase; Fig. 3D ). TH-ir cell density was calcu-enolase (NSE) and β-III-tubulin ( Fig. 7 ). lated and a significant increase was found in the treated DISCUSSION group compared to controls (57.6 ± 2.4 vs. 44.7 ± 4.1 cells per mm 2 , 29% increase, Fig. 3F, Fig. 4 ).
During the last decade, strong evidence has grown that impaired cellular energy metabolism, particularly Effects of Creatine After MPP + Exposure defective mitochondrial function, contributes to neuronal death in PD (13, 40, 63, 76) as well as in other neu-Exposure of the cultures to the neurotoxin MPP + (15 µM) resulted in a significantly lower density of TH-ir rodegenerative disorders, such as Huntington's disease (HD) (9, 17, 38) , progressive supranuclear palsy (PSP) neurons, as assessed at DIV7 and compared to untreated controls (53.3 ± 2.9 vs. 65.6 ± 5.5 cells per mm 2 , 19% (5,12,56), Alzheimer's disease (AD) (3, 8, 47, 72) , and amyotrophic lateral sclerosis (ALS) (13, 16, 22, 30) . decrease). Creatine administration resulted in a protection against the insult with significant higher densities Reduced mitochondrial complex-I activity and consecutive production of cytotoxic reactive oxygen species of TH-ir cells compared to cultures exposed to MPP + but not receiving creatine (70.2 ± 4.6 vs. 53.3 ± 2.9 cells (ROS) has been found in patients suffering from idiopathic PD (49,55,77). Maternally inherited forms of PD per mm 2 ) (Fig. 5, Fig. 6A ). In cultures exposed to MPP + , a higher number of active caspase-3-ir cells was found associated with complex-I deficiency furthermore support the hypothesis concerning a mitochondrial involve-compared to untreated controls (165.7 ± 11.1 vs. 136.6 ± 9.2 cells per mm 2 , 21% increase), as assessed at DIV7. ment in the pathogenesis of the disorder (39, 84, 85) . Administration of the neurotoxin MPP + , which acts as a However, this effect was not statistically significant. Creatine treatment showed a markedly attenuated in-potent complex-I inhibitor and exerts its neurotoxic potential through disruption of the mitochondrial respira-crease in the number of cells immunoreactive for active caspase-3 after exposure to MPP + than cultures not cre-tory chain (86), induces lesions similar to those found in PD in the brains of exposed animals and humans. atine supplemented (Fig. 6B) . Improving the metabolic state of neuronal cells may in the treated tissue is a mandatory condition for cellular benefit of creatine supplementation. Our analyses showed therefore offer an additional therapeutic strategy for the treatment of PD.
that the cytosolic BB isotype of CK was present in FFRT-cultured E14 rat ventral mesencephalon in respect-Several studies have reported that creatine supplementation has neuroprotective effects in various disor-able amounts (about 2% of total tissue protein content) and increased considerably during the in vitro period up ders associated with premature neuronal death. Protective effects have been found in normal hippocampal to DIV21. Corresponding results have previously been shown for the in vivo BB-CK content in the developing cells against neurotoxins (15) as well as in different animal models of neurodegeneration (6,29,51,57,83), ische-rat brain, where it appears to decrease slightly during embryonal development in utero and rapidly reaches mia (96,100), and trauma (78, 90) . Creatine-induced neuroprotection has also been demonstrated in several in adult levels by a quadruple increase in the early postnatal period (20, 46, 67) . Regarding the fact that the early vitro models of neurotoxicity and metabolic insults (15, 19, 61, 92) . Therefore, creatine is suggested to have postnatal period corresponds to the days following DIV7 in tissue derived from E14 embryos, the pattern of BB-potential as a therapeutic molecule for the treatment of PD (28, 50) . Regarding these findings, it should be ratio-CK expression seems to show only minor quantitative changes in an organotypic ex vivo environment. How-nal to assume a creatine-mediated benefit on embryonic neuronal precursor cells. In the present study, we inves-ever, creatine supplementation resulted in a significant upregulation of BB-CK expression in the treated cul-tigated the possible effects on cultured embryonal mesencephalic tissue. Long-term survival of TH-ir neurons tures grown for 1 week. Because the BB-CK content in the cultured tissue was substantial and colocalization in culture is a key factor for the efficiency of neurotransplantation approaches in PD. studies confirmed its abundant presence in TH-ir neurons at DIV14, we postulate that the missing effects of The presence of sufficient amounts of functional CK chronic creatine treatment on dopaminergic cell density plicability of this particular model for the investigation of cell survival of dopaminergic neurons by creatine up to DIV14 are not due to insufficient presence of creatine kinases. may be not appropriate for relatively short culture periods. However, we were able to demonstrate protective The observation that creatine exposure failed to increase survival of dopaminergic neurons in cultures up effects of creatine on dopaminergic cell survival in a period when significant cell loss occurs in the FFRT cul-to DIV14 but was effective between DIV14 and DIV21 may be based on the fact that we used an organotypic tures (i.e., after 12 days in vitro) (45) . Furthermore, it has to be considered that the cellular energy metabolism culture system. In monolayer cultures of embryonic rat VM origin a continuous loss of TH-ir cells, most promi-reserves of dopaminergic cells may be sufficient under standard culture conditions in the early in vitro period, nent during the first days in culture, has been demonstrated (27, 99) . In contrast, our study comprised tissue but creatine addition might boost ATP resources and facilitate metabolic channeling at a later time point, when cultured using the FFRT method, which allows storage of embryonic VM prior to transplantation without a ma-axonal and dendritic outgrowth and synaptogenesis occur and much higher energy demands result due to aug-jor loss of dopaminergic neurons for a time period of at least 1 week (45) . This is likely due to the preservation mented protein synthesis, impaired spatial configuration of the metabolic pathways, and beginning electrophysio-of cell to cell interactions and of the natural cytoarchitecture in the organotypic culture system. Hence, the ap-logical activity. Based on this notion, it is suggested that the usage of cultures with a significantly smaller extent reported to contribute to the loss of embryonic dopaminergic nigral cells in culture (21, 62) . Programmed cell of cell-cell contact than the organotypic FFRT approach might result in a more pronounced effect of creatine death occurring as a natural phenomenon in a biphasic pattern with a first peak of apoptotic dopaminergic neu-treatment on dopaminergic neurons survival. However, this was not the primary goal of the recent study, which rons around postnatal day 2 (70) has been shown in the developing rat substantia nigra. This time point would addressed ways for improvement of tissue quality prior to transplantation when tissue properties should not be correspond to DIV9 for cultures initiated at E14, consistent with the period of pronounced cell loss between too much altered.
The reasons for loss of dopaminergic cells in vitro DIV8 and DIV12 we reported previously (45) . Despite intense research activities in this field during are still debated. Pathophysiological mechanisms like excitotoxicity (41, 75) or free radical generated toxicity the last years, the precise mechanisms underlying the effects of creatine on neuronal survival still remain un-(66) may contribute to cell death. Apoptosis has been B) , and β-III-tubulin (C) in FFRT cultures grown for 7 days in vitro and exposed to MPP + (15 µM) at DIV3 and DIV5 in the absence (MPP + ) or presence of creatine (5 mM) (Comb). Cultures not exposed to MPP + grown without (Co) or with creatine (5 mM) (Cr) served as controls. Creatine treatment did not result in altered expression of TH, NSE, or β-III-tubulin. MPP + exposure resulted in significantly lower levels of TH protein expression in the cultures. Concurrent creatine treatment partially protected against this decrease. clear (19) . In particular, it remains to be elucidated concentration of 5 mM to the culture medium. However, the optimal period for transplantation has been deter-whether neuroprotective effects are primarily induced by support of the cellular energy metabolism alone or if mined to be significantly earlier by previous studies. For rat ventral mesencephalic cultures grown longer than 1 there is significant involvement of direct antiapoptotic effects as reported in other studies (68, 92) . However, a
week, poor graft survival and recovery is expected based on in vitro data (45) , a fact that limits the potential of recent publication failed to detect activity of this mechanism in isolated rat brain mitochondria pretreated with creatine treatment in this paradigm. On the other hand, creatine administration to the recipient of the grafts creatine (19) . It should not be excluded, however, that attenuation of the mitochondrial permeability transition might be effective in improving survival and integration of dopaminergic cells after transplantation. We hypothe-by creatine contributes to neuroprotection in intact neurons.
size that a combination of creatine treatment with transplantation of creatine-pretreated VM FFRT cultures may NMDA receptor-mediated excitotoxicity has been shown to contribute to TH-ir cell loss in vitro (79) .
provide an appropriate method to further enhance graft survival. In addition, given the supposed protective ef-There is evidence for a protective potential of creatine against NMDA excitotoxicity (19, 57) . However, addi-fects of creatine on dopaminergic cells suffering compromised energy metabolism, the creatine diet may also tion of the noncompetitive NMDA antagonist dizocilpine hydrogen maleate (MK-801; RBI) at a concentra-slow down the progressing cell loss in PD. Notably, creatine supplementation shows low side effects even at tion of 50 µM to the culture medium had no effect on the survival of dopaminergic neurons in untreated FFRT high dosages (37, 52) . In combination with growth factors, effects of creatine may be found earlier and/or cultures nor did it influence the effects of creatine treatment in our setup (data not shown). It might be possible more pronounced due to the induction of differentiation and higher energetic demands. that the close glia-neuron interaction in organotypic cultures is responsible for the missing excitotoxic effects.
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